These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 19201471)

  • 21. Input of selected human pharmaceutical metabolites into the Norwegian aquatic environment.
    Langford K; Thomas KV
    J Environ Monit; 2011 Feb; 13(2):416-21. PubMed ID: 21152649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical compounds in the wastewater process stream in Northwest Ohio.
    Spongberg AL; Witter JD
    Sci Total Environ; 2008 Jul; 397(1-3):148-57. PubMed ID: 18396321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A pilot study for the assessment of pharmaceuticals as water contaminants].
    Bottoni P; Fidente R
    Ann Ist Super Sanita; 2005; 41(3):333-42. PubMed ID: 16552124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical and personal care products in tile drainage following land application of municipal biosolids.
    Lapen DR; Topp E; Metcalfe CD; Li H; Edwards M; Gottschall N; Bolton P; Curnoe W; Payne M; Beck A
    Sci Total Environ; 2008 Jul; 399(1-3):50-65. PubMed ID: 18455753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A field study on 8 pharmaceuticals and 1 pesticide in Belgium: removal rates in waste water treatment plants and occurrence in surface water.
    Van De Steene JC; Stove CP; Lambert WE
    Sci Total Environ; 2010 Jul; 408(16):3448-53. PubMed ID: 20471061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical contamination in residential, industrial, and agricultural waste streams: risk to aqueous environments in Taiwan.
    Lin AY; Yu TH; Lin CF
    Chemosphere; 2008 Dec; 74(1):131-41. PubMed ID: 18829065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation.
    Besse JP; Garric J
    Toxicol Lett; 2008 Jan; 176(2):104-23. PubMed ID: 18077113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment.
    Verlicchi P; Al Aukidy M; Galletti A; Petrovic M; Barceló D
    Sci Total Environ; 2012 Jul; 430():109-18. PubMed ID: 22634557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exposure assessment of the pharmaceutical diclofenac based on long-term measurements of the aquatic input.
    Letzel M; Metzner G; Letzel T
    Environ Int; 2009 Feb; 35(2):363-8. PubMed ID: 19027956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sources of pharmaceutical pollution in the New York City Watershed.
    Palmer PM; Wilson LR; O'Keefe P; Sheridan R; King T; Chen CY
    Sci Total Environ; 2008 May; 394(1):90-102. PubMed ID: 18280543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceuticals in the river Elbe and its tributaries.
    Wiegel S; Aulinger A; Brockmeyer R; Harms H; Löffler J; Reincke H; Schmidt R; Stachel B; von Tümpling W; Wanke A
    Chemosphere; 2004 Oct; 57(2):107-26. PubMed ID: 15294435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceuticals in on-site sewage effluent and ground water, Western Montana.
    Godfrey E; Woessner WW; Benotti MJ
    Ground Water; 2007; 45(3):263-71. PubMed ID: 17470115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbamazepine, diclofenac, ibuprofen and bezafibrate--investigations on the behaviour of selected pharmaceuticals during wastewater treatment.
    Strenn B; Clara M; Gans O; Kreuzinger N
    Water Sci Technol; 2004; 50(5):269-76. PubMed ID: 15497857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial ecological risk assessment of eight selected human pharmaceuticals in Japan.
    Yamamoto H; Nakamura Y; Nakamura Y; Kitani C; Imari T; Sekizawa J; Takao Y; Yamashita N; Hirai N; Oda S; Tatarazako N
    Environ Sci; 2007; 14(4):177-93. PubMed ID: 17762841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters.
    Lindqvist N; Tuhkanen T; Kronberg L
    Water Res; 2005 Jun; 39(11):2219-28. PubMed ID: 15935437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The occurrence of acidic drugs and caffeine in sewage effluents and receiving waters from three coastal watersheds in Atlantic Canada.
    Comeau F; Surette C; Brun GL; Losier R
    Sci Total Environ; 2008 Jun; 396(2-3):132-46. PubMed ID: 18377954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.
    Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
    Environ Pollut; 2009 May; 157(5):1721-6. PubMed ID: 19201071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of the antidiabetic drug metformin in sewage and surface waters in Germany.
    Scheurer M; Sacher F; Brauch HJ
    J Environ Monit; 2009 Sep; 11(9):1608-13. PubMed ID: 19724829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ecotoxicology of human pharmaceuticals.
    Fent K; Weston AA; Caminada D
    Aquat Toxicol; 2006 Feb; 76(2):122-59. PubMed ID: 16257063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain).
    Santos JL; Aparicio I; Alonso E
    Environ Int; 2007 May; 33(4):596-601. PubMed ID: 17084895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.